top of page
Rock Balancing

CRO

SERVICES

OUR SERVICES

CLIENT

SAMPLE 

Plasma
Urine
Tissue
Saliva
Other

SAMPLE

ANALYSIS

DATA

ANALYSIS

DATA

INTERPRETATION

CLIENT

REPORT

Sample Storage
Chain of Custody
Analyte Extraction
  • metabolomics
  • lipidomics
  • quantitative assay
  • structure elucidation
Data Storage
Data Management
Data Access
​
Statistical Analysis
  • 3k metabolite features
  • tailored
  • scalable
Biochemical
  • Core Lab
​
Clinical
  • on-site MDs
Big Data
Cloud Computing
Visualizatioin
72dpi-02.png

AREAS OF EXPERTISE

KIDNEY DISEASE
& DIABETES

Statistics ​

  • Roughly 850 million people worldwide have chronic kidney disease (CKD)

  • Diabetes is the leading cause (44% of all new cases) of kidney failure

  • 9 out of 10 people with stage 3 CKD do not know it

  • An estimated 415 million people worldwide have diabetes; 46% are undiagnosed

CKD and diabetes are systemic diseases that result in changes to specific metabolic functions throughout the body. While key metabolites and biomarkers have been used to identify presence of these diseases, much work remains in the effort to develop complete diagnostic solutions. In response to the Executive Order on Advancing American Kidney Health, JUNO is driving the first steps of CKD and diabetes diagnostics through metabolomics analysis of the following indices:

  • Kidney Function (GFR)

  • Renal Functional Reserve

  • ESRD Outcomes Management

  • Progression of Diabetic Kidney Disease (DKD)

  • Type 2 Diabetes (T2D) Subtypes

  • Other Upon Request

MEDICAL CANNABIS 

Common Questions â€‹

  • Is medical cannabis safe?

  • How effective is it?

  • Which conditions can it treat?

  • How do various cannabis strains and hybrids differ and how does one know which to use?

  • Are medical cannabis products third party tested for purity and potency? 

JUNO aims to bring answers to the medical cannabis community through targeted and global metabolomics analysis. See also: JUNOKANA integrated platform solution for medical cannabis. 

  • Targeted Analysis of THC and CBD Products

  • Targeted Analysis of Amino Acids and Acylcarnitines

  • Global Metabolomics and Lipidomics via LC-HRMSMS

    • Plasma​

    • Serum

    • Urine

    • Plant

  • Statistical Analysis

    • Machine Learning​

    • Multivariate Statistics

    • Univariate Statistic

FUTURE PIPELINE:

MICROBIOME
LIVER DISEASE / NASH
Juno_Lab1.jpg
Juno_Lab_2.jpg
bottom of page